Strides Pharma Science appoints Dr. C. Muthulingam as Executive VP - R&D
Dr. Muthu was last associated with Mankind Pharma
Dr. Muthu was last associated with Mankind Pharma
He did Master’s of Pharmacy (Pharmaceutical Technology, Formulations) from National Institute of Pharmaceutical Education and Research, Mohali and Bachelor of Pharmacy from Osmania University
He specializes in financial planning, audit, compliance and ERP implementation, with extensive experience in leading automation and risk management projects
Diltiazem Hydrochloride Extended-Release Capsules USP are indicated for the treatment of hypertension
Medanta is expected to incur a project capex of ~Rs. 600 crores in next 3-4 years
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The workshop aimed to equip medicos with the necessary skills & knowledge to leverage AI's transformative power
This partnership will enable healthcare organizations to provide best-in-class patient/consumer experiences
Subscribe To Our Newsletter & Stay Updated